Global R&D Spend In The Biopharmaceutical Industry Accounted For USD 194 Billion In 2016 Tends To Drive The Biologics Drug Discovery Market
The global market for biologics drug discovery market reached nearly USD 56.6 billion in 2016 and is expected to reach USD 140.9 billion by 2024 at the CAGR of 12% over the forecast period.
Over 20 new drugs were launched in the market between 2000-2005, originated from terrestrial plants, terrestrial microorganisms, marine organisms and terrestrial vertebrates and invertebrates. For instance, the main purpose of Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection is to supply the Novartis drug discovery pipeline with hit to lead drugs/compounds for present and future portfolios of drug discovery programs. There are many drug discovery approaches targeting the cancerous cells by Novartis Institutes for Biomedical Research, Switzerland and Cambridge. The drug discovery procedure is long, arduous and costly, which has encouraged outsourcing in the drug discovery field.
According to Goldstein Research, global biologics drug discovery market is segmented on the basis of technology and by end-user. Technology segment is further categorized into Q-PCR, DNA microarrays, protein microarrays, high-throughput screening, mass spectrometry, gel electrophoresis, chromatography, protein and nucleic acid isolation and other technologies.High throughput screening is widely adopted drug discovery technology owing to the fact that it enables portfolio construction of biologically relevant compounds quickly. The global biologics drug discovery market North America holds the largest market share in the global drug discovery market owing to the concentration of world’s leading pharmaceutical companies.
The global biologics drug discovery market 2016-2024 covers the present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe. Moreover, the competitive analysis includes the in-depth analysis of the major players and leaders in the healthcare industry. The market study conducted on the basis of primary as well as secondary research where the analysts fragment the data from various databases such as Bloomberg, Factiva, Owler, and others. Our primary research team conducted various interviews, surveys and group discussions of industry biologics drug discovery manufacturers, suppliers, and distributors, pharmaceutical & biotechnology companies, healthcare institutions, clinical centers, medical research laboratories and academic medical centers and universities to analyze the future prospects of the overall healthcare industry.
Global Biologics Drug Discovery Market Segmentation can be classified on the basis of:
By Technology
- Q-PCR
- DNA Microarrays
- Protein Microarrays
- High-throughput screening
- Mass Spectrometry
- Gel Electrophoresis
- Chromatography
- Protein and Nucleic Acid Isolation
- Other technologies
By End User
- Outsourcing (Contract Research Organization)
- Insourcing (Within the Organization)
By Geography
- North America (US, Canada)Biologics Drug Discovery Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) Biologics Drug Discovery Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) Biologics Drug Discovery Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Latin America (Brazil, Mexico and Rest of Latin America)Biologics Drug Discovery Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) Biologics Drug Discovery Market {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Download Exclusive Sample Report @ https://www.goldsteinresearch.com/request-sample/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024
Market Trends, Drivers & Challenges
Increasing penetration of biologics up to 30% due to the key modalities like monoclonal antibodies, recombinant proteins, peptides, cell and gene therapy products is trending in biologics drug discovery market. In addition, the surge in the externalization and outsourcing activities is favoring the shift towards biologics. Patents of drugs expire that tends to make the lucrative market for the existing players. In US and Canada, biologics drug discovery market is high due to promising healthy potential returns on investments and high-income population. However, the shift from traditional methods to personalized drug discovery is hindering the global biologics drug discovery market. Delay in government approval for drug discovery and huge investment favoring the shift from market branded drugs to generic drugs are the challenges faced by biologics drug discovery industry.
“Global Biologics drug Discovery market Report” has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the market space. The report also includes Porter's five force model, SWOT analysis, company profiling, business strategies of market players and their business models. The global biologics drug discovery market report also recognizes value chain analysis to understand the cost differentiation to provide a competitive advantage to the existing and new entry players.
About Us
Based in the U.S., Goldstein Research is a young business consulting and market research agency with vast reach across America, Asia and parts of Europe and the Middle East. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions. With 30+ domain experts and 50+ employees working day and night to crunch numbers and bring out the best and detailed market reports and forecasts, we strive to enable you to foresee upcoming market challenges and develop a robust business model and strategies, which would add to your profitability and market visibility as a brand.
Media Contact
Company Name: Goldstein Research
Contact Person: Steve Blade
Email:Send Email
Phone: +1-6465687747
Address:99 Wall Street, Suite No:- 527
City: New York
State: NY
Country: United States
Website: http://www.goldsteinresearch.com/
